APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,665,340 | -9.3% | 122,643 | +117.3% | 0.40% | -8.1% |
Q2 2023 | $5,142,504 | -35.8% | 56,449 | -63.5% | 0.43% | -38.7% |
Q4 2022 | $8,004,501 | +92.1% | 154,796 | +22.5% | 0.70% | +142.6% |
Q3 2021 | $4,166,144 | +652.6% | 126,400 | +879.8% | 0.29% | +588.1% |
Q1 2021 | $553,539 | +153.6% | 12,900 | +238.1% | 0.04% | +61.5% |
Q4 2020 | $218,275 | -91.1% | 3,816 | -95.3% | 0.03% | -95.2% |
Q3 2020 | $2,451,825 | -82.2% | 81,267 | -80.7% | 0.54% | -71.1% |
Q2 2020 | $13,747,639 | -42.9% | 420,932 | -53.2% | 1.88% | -68.5% |
Q1 2020 | $24,096,908 | +153.5% | 899,474 | +189.8% | 5.99% | +257.0% |
Q4 2019 | $9,504,724 | +396.2% | 310,409 | +290.4% | 1.68% | +182.5% |
Q3 2019 | $1,915,372 | -35.6% | 79,509 | -32.2% | 0.59% | -28.6% |
Q2 2019 | $2,972,610 | +46.1% | 117,309 | +12.4% | 0.83% | +40.1% |
Q1 2019 | $2,034,806 | +44.3% | 104,349 | -2.4% | 0.59% | -22.1% |
Q4 2018 | $1,409,747 | -20.9% | 106,880 | +6.6% | 0.76% | -2.6% |
Q3 2018 | $1,783,245 | -17.6% | 100,295 | +1.9% | 0.78% | -20.9% |
Q2 2018 | $2,164,690 | – | 98,395 | – | 0.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |